Company to send 12 million doses of COVID-19 vaccine adapted to target Omicron.
Moderna is supplying Canada with 12 million COVID-19 shots specifically designed to target the Omicron variant of COVID-19.
Last year, the Canadian government entered into a supply deal with the company for supply of its COVID vaccine for 2022 and 2023.
The contract does allow for access to new adaptations of the vaccine.
Moderna and Canada have agreed to convert six million doses of the company's COVID vaccine, which targets the original virus, to an Omicron-containing bivalent one.
The country will also purchase an addition 4.5 million doses of the Omicron-targeted shot, and is moving forward with a scheduled delivery of 1.5 million shots of the bivalent vaccine.
While existing COVID-19 inoculations continue to provide protections against hospitalization and death, experts say the effectiveness of the vaccine has decreased as the virus has evolved.
Chief Public Health Officer Dr. Theresa Tam says Health Canada is still reviewing submissions for bivalent vaccines from Moderna and Pfizer.

Oxford County Receives Investment for Emergency Preparedness
New Canada-Ontario Partnership Focuses on Affordability
Interview with the Mayor - March 30th, 2026
Woodstock Has Two Easter Events This Week!
PJHL Playoff Recap - March 27th to March 29th
Applications Open for WAG Legacy Scholarship
A Busy April for Woodstock Chamber of Commerce
Avi Lewis Named Federal NDP Leader
OPP Runs 'Stay Focused' Campaign
Rec & Leisure Fair is Back
Oxford Stewardship Award Nominees Announced
United Way Thanks Community for Successful Campaign
Budget Supports Home Buying, Small Business
Impaired Driver Charged in Ingersoll
Scratch Ticket Turns into $50,000 for Woodstonian
Interview with the Warden - March 26th, 2026
WCI Captains/Veterans Basketball Game Returns!
Baxter Named PJHL Trainer of the Year
Ontario to Table 2026 Budget Today
UPDATE: Federal Offender Arrested in Kingston
Comments
Add a comment